Akanda (AKAN) Competitors $1.37 -0.03 (-2.14%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestTrends AKAN vs. GLTO, EYEN, SYRS, BIOR, BCLI, EDSA, GTBP, EVOK, CANF, and ABVCShould you be buying Akanda stock or one of its competitors? The main competitors of Akanda include Galecto (GLTO), Eyenovia (EYEN), Syros Pharmaceuticals (SYRS), Biora Therapeutics (BIOR), Brainstorm Cell Therapeutics (BCLI), Edesa Biotech (EDSA), GT Biopharma (GTBP), Evoke Pharma (EVOK), Can-Fite BioPharma (CANF), and ABVC BioPharma (ABVC). These companies are all part of the "pharmaceutical products" industry. Akanda vs. Galecto Eyenovia Syros Pharmaceuticals Biora Therapeutics Brainstorm Cell Therapeutics Edesa Biotech GT Biopharma Evoke Pharma Can-Fite BioPharma ABVC BioPharma Galecto (NASDAQ:GLTO) and Akanda (NASDAQ:AKAN) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, community ranking, media sentiment, risk, profitability, earnings and institutional ownership. Which has more risk & volatility, GLTO or AKAN? Galecto has a beta of 1.24, meaning that its stock price is 24% more volatile than the S&P 500. Comparatively, Akanda has a beta of 1.51, meaning that its stock price is 51% more volatile than the S&P 500. Does the media refer more to GLTO or AKAN? In the previous week, Galecto had 2 more articles in the media than Akanda. MarketBeat recorded 2 mentions for Galecto and 0 mentions for Akanda. Galecto's average media sentiment score of 0.58 beat Akanda's score of 0.00 indicating that Galecto is being referred to more favorably in the media. Company Overall Sentiment Galecto Positive Akanda Neutral Do analysts rate GLTO or AKAN? Galecto currently has a consensus target price of $10.00, suggesting a potential upside of 72.12%. Given Galecto's stronger consensus rating and higher possible upside, research analysts clearly believe Galecto is more favorable than Akanda.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Galecto 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Akanda 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has higher earnings and valuation, GLTO or AKAN? Akanda has higher revenue and earnings than Galecto. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGalectoN/AN/A-$38.35M-$19.14-0.30Akanda$2.51M0.78-$32.28MN/AN/A Does the MarketBeat Community believe in GLTO or AKAN? Galecto received 32 more outperform votes than Akanda when rated by MarketBeat users. CompanyUnderperformOutperformGalectoOutperform Votes3260.38% Underperform Votes2139.62% AkandaN/AN/A Is GLTO or AKAN more profitable? Akanda's return on equity of 0.00% beat Galecto's return on equity.Company Net Margins Return on Equity Return on Assets GalectoN/A -76.96% -66.59% Akanda N/A N/A N/A Do insiders and institutionals hold more shares of GLTO or AKAN? 14.2% of Galecto shares are held by institutional investors. Comparatively, 1.0% of Akanda shares are held by institutional investors. 11.9% of Galecto shares are held by company insiders. Comparatively, 20.4% of Akanda shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. SummaryGalecto beats Akanda on 7 of the 13 factors compared between the two stocks. Ad Weiss RatingsTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. Get Akanda News Delivered to You Automatically Sign up to receive the latest news and ratings for AKAN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AKAN vs. The Competition Export to ExcelMetricAkandaMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.96M$1.33B$5.05B$8.87BDividend YieldN/AN/A4.97%4.06%P/E RatioN/A29.1597.3414.18Price / Sales0.788.961,218.4289.42Price / CashN/A11.9133.5132.79Price / Book-0.022.155.805.12Net Income-$32.28M-$52.95M$119.07M$225.99M7 Day Performance-7.43%-3.61%-1.83%-1.32%1 Month Performance-35.98%-3.14%-3.64%0.60%1 Year Performance-96.02%5.58%31.62%26.23% Akanda Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AKANAkandaN/A$1.37-2.1%N/A-96.0%$1.96M$2.51M0.00110GLTOGalecto3.1132 of 5 stars$5.81-1.5%$10.00+72.1%-60.6%$7.77MN/A0.0040Gap UpEYENEyenovia3.3686 of 5 stars$0.09-24.5%$2.00+2,064.5%-93.2%$7.64MN/A0.0040Analyst DowngradeShort Interest ↓Analyst RevisionNews CoverageGap DownHigh Trading VolumeSYRSSyros Pharmaceuticals4.3364 of 5 stars$0.29+3.6%$3.33+1,049.4%-89.9%$7.43M$9.94M0.00120Analyst RevisionGap UpBIORBiora Therapeutics2.5866 of 5 stars$1.62-0.6%$23.00+1,319.8%-87.9%$7.37MN/A0.00120Analyst ForecastBCLIBrainstorm Cell Therapeutics4.4456 of 5 stars$1.26+0.8%$30.00+2,281.0%-53.4%$7.13MN/A-0.2640Analyst UpgradePositive NewsEDSAEdesa Biotech3.1439 of 5 stars$2.20+0.5%$21.00+854.5%-27.9%$7.11MN/A0.0020Gap UpGTBPGT Biopharma0.206 of 5 stars$3.19+1.6%N/A-54.2%$7.01MN/A0.008EVOKEvoke Pharma0.0483 of 5 stars$4.56-3.0%N/A-69.5%$6.98M$5.18M0.004Analyst ForecastCANFCan-Fite BioPharma1.8046 of 5 stars$1.97-3.0%$18.00+813.7%-1.7%$6.97M$667,000.00-1.108Analyst DowngradeNews CoverageABVCABVC BioPharma0.7443 of 5 stars$0.57+7.6%N/A-66.4%$6.81M$150,000.000.0030Gap Up Related Companies and Tools Related Companies GLTO Competitors EYEN Competitors SYRS Competitors BIOR Competitors BCLI Competitors EDSA Competitors GTBP Competitors EVOK Competitors CANF Competitors ABVC Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:AKAN) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akanda Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Akanda With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AKAN Stock Alerts